{"id":102594,"title":"Poolbeg Pharma PLC (AIM:POLB) Upcoming Events","publisher":"Share Talk","author":"sharetalk","published":"2022-10-21T06:20:57+00:00","modified":"2022-10-21T06:20:57+00:00","canonical_url":"https://www.share-talk.com/poolbeg-pharma-plc-aimpolb-upcoming-events/","markdown_url":"https://www.share-talk.com/poolbeg-pharma-plc-aimpolb-upcoming-events.md","json_url":"https://www.share-talk.com/poolbeg-pharma-plc-aimpolb-upcoming-events.json","category":"Healthcare","categories":["Healthcare","Pharmaceutical"],"tags":["Cathal Friel","immunomodulator","Influenza","Jeremy Skillington","molecule","Open Orphan","ORPH","POLB","Poolbeg Pharma","respiratory","Share Talk","Syncytial","US Patent","virus"],"featured_image":"https://i0.wp.com/www.share-talk.com/wp-content/uploads/2023/11/Stencil-Google-Chrome-2023-04-19-at-2.47.43-PM.jpeg?fit=1231%2C615&quality=89&ssl=1","format":"news","language":"en-GB","content":"21 October 2022 – **Poolbeg Pharma (AIM: POLB, OTCQB: POLBF),** a clinical stage infectious disease pharmaceutical company with a capital light clinical model, announces that its management and business development team will be attending and presenting at a number upcoming partnering and investor events from October 2022 to January 2023.\n\n**Partnering events**\n\n• BIO-Europe from 24-26 October 2022 at Leipzig Messe, Leipzig, Germany 04356\n\n• Jefferies London Healthcare Conference from 15-17 November 2022 in London\n\n• JP Morgan 41st Annual Healthcare Conference from 9-12 January 2023 at the Westin St. Francis Hotel, San Francisco, CA\n\n**Investor events**\n\n• London South East Webinar (virtual) on 8 November 2022. Register here\n\n• LSX Inv€$tival ShowcaseTM on 14 November 2022 at Old Billingsgate, London EC3R 6DX. Poolbeg CEO, Jeremy Skillington, will present at 14:15 on Stage 4: Biotech Late Growth. Register here\n\nEvent details may be subject to change – further information and updates are available on the Poolbeg Pharma website here .\n\n– Ends –\n\nEnquiries\n\n**Poolbeg Pharma Plc**\n\n**Jeremy Skillington, CEO**\n\n**Ian O’Connell, CFO**\n\n**+44 (0) 20 7183 1499**"}